|
Variables
|
(n = 18)
|
(n = 21)
| |
|
Age, mean ± SD, (years)
|
37.22 ± 7.83
|
38.76 ± 8.08
|
0.582
|
|
Gender, (n)
|
|
Male
|
13
|
14
| |
|
Female
|
5
|
7
|
0.742
|
|
Duration of symptoms,
|
|
mean ± SD, (days)
|
25.06 ± 16.09
|
21.33 ± 15.63
|
0.359
|
|
Baseline BCVA, mean ± SD,
|
|
(ETDRS)
|
63.67 ± 9.79
|
62.81 ± 8.52
|
0.772
|
|
Baseline CFT, mean ± SD,
|
|
(μm)
|
427.28 ± 52.23
|
423.38 ± 47.39
|
0.808
|
|
Baseline retinal
|
|
sensitivity, mean ± SD, (dB)
|
12.29 ± 1.88
|
12.61 ± 1.95
|
0.601
|
|
Presence of macular PED, (n)
|
3(16.7%)
|
5(23.8%)
|
0.702
|
|
Location of leakage site, (n)
|
|
Subfoveal
|
2
|
4
| |
|
Juxtafoveal
|
14
|
15
| |
|
Extrafoveal
|
2
|
2
|
0.789
|
|
Number of leakage point, (n)
|
|
1
|
15
|
16
| |
|
2
|
3
|
4
| |
|
3
|
0
|
1
|
0.622
|
